BusinessAgile Therapeutics to Present at the Cantor Fitzgerald Global Healthcare ConferenceBy Nasdaq OMXSep 14, 2017, 11:45 AM UTC
BusinessAgile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Contraceptive Patch, Twirla®By Nasdaq OMXJun 27, 2017, 12:00 PM UTC
BusinessAgile Therapeutics Announces a Poster Presentation of its SECURE Phase 3 Study at the Contraceptive Technology 2017 ConferenceBy Nasdaq OMXMar 16, 2017, 8:30 PM UTC
